DESTIN, Fla. — Raising the rheumatology community’s “aspirations” for immune-mediated inflammatory disease treatment could lead to better patient outcomes, according to a speaker at the Congress of Clinical Rheumatology East annual meeting.“Most of our decisions in chronic disease are not bad, but they do not resolve the condition,” Iain McInnes, MD, PhD,
The latest news from the CCR annual meetings, and the accompanying North American Young Rheumatology Investigator Forum, including perspectives and interviews with leading researchers and…
A consensus statement published in Endocrine Practice examines how health care professionals should approach treating and screening people with tumors associated with multiple endocrine neoplasia…
An AI model trained on analyzing ultrasound images and molecular testing results may assist health care professionals treating indeterminate thyroid nodules, researchers stated in a…
Click on the article title to read more.
Artificial intelligence can improve care for patients with primary immunodeficiencies, but human input is still necessary, Nicholas L. Rider, DO, said at Updates in Primary…
In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for…
Reverse shoulder arthroplasty (RSA) with structural bone grafting of the glenoid utilizing an autograft from the resected humeral head is an effective strategy to address…
To systematically review studies using video analyses to evaluate anterior cruciate ligament (ACL) injury mechanisms in athletes during sport to better understand risk factors and…
🎤Get ready for the ultimate showdown in rheumatology education – the RheumaVision Grand Finale at #EULAR2025!🔥Six finalists! Five-minute talks! And YOU get…
DESTIN, Fla. — An increasing array of B-cell targeting approaches may aid clinicians in managing the cycles and flares of lupus, according to a speaker…
